Genomtec

Genomtec EBITDA per Employee

EBITDA per Employee of Genomtec (GMT.WA) as of Nov 10, 2026.

EBITDA per Employee

-PLN

Last updated:

EBITDA per Employee of Genomtec is 2026 - PLN. EBITDA per Employee of Genomtec was 2025 - PLN. It decreases by % lower compared to the previous year.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Get Free API Key

Genomtec Stock analysis

What does Genomtec do? Genomtec SA generates revenue by researching and developing molecular diagnostic equipment, specifically focusing on the Genomtec ID mobile platform. This technology enables genetic diagnosis at the point of patient care, eliminating the need for complex laboratory workflows and qualified personnel. The platform is designed for use in primary care clinics, pharmacies, doctor’s offices, and hospital emergency departments. Genomtec is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Genomtec stock

On Eulerpool you can find the complete historical development of EBITDA per Employee Genomtec since 2006 – with annual values, charts, and detailed analysis.

EBITDA per employee measures operating cash earnings generated per employee, showing workforce productivity before depreciation and financing effects.

EBITDA per Employee's PLN is a key factor for investors. Changes in this metric can signal improving or deteriorating fundamentals, directly impacting the stock price. On Eulerpool, you can track EBITDA per Employee's Genomtec historically and in real time.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Get Free API Key

Workforce — Genomtec

EmployeesRevenue per EmployeeProfit per EmployeeMarket Cap per EmployeeEBIT per EmployeeEBITDA per EmployeeR&D per EmployeePP&E per Employee

All Key Metrics — Genomtec